Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 992-1004
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.992
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Analysis of 5-year survival rate of 2604 cases of advanced gastric cancer based on Borrmann type and lymphatic and/or blood vessel invasion (LBVI). A: Borrmann tupe; B: LBVI status.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Effect of Borrmann type combined with lymphatic and/or blood vessel invasion (LBVI) status on long-term survival of patients with advanced gastric cancer. A: Borrmann type I + LBVI status; B: Borrmann type II + LBVI status; C: Borrmann type III + LBVI status; D: Borrmann type IV + LBVI status.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Prognostic impact of incorporating lymphatic and/or blood vessel invasion (LBVI) status into Borrmann types III and IV advanced gastric cancer. A: Borrmann type III + LBVI (+); B: Borrmann type IV + LBVI (-).
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Prognostic significance of Borrmann type with lymphatic and/or blood vessel invasion (LBVI) status among different pT stages of advanced gastric cancer. A: pT2; B: pT3; C: pT4a; D: pT4b.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Prognostic significance of Borrmann type with lymphatic and/or blood vessel invasion (LBVI) status among advanced gastric cancer at different locations. A: Upper third; B: Middle third; C: Lower third; D: Overlapping tumors.